Connect
MJA
MJA

Profound hypocalcaemia after zoledronic acid treatment

Huong V Nguyen, Katherine B Ingram and Jonathan Beilin
Med J Aust 2005; 182 (9): . || doi: 10.5694/j.1326-5377.2005.tb06797.x
Published online: 2 May 2005

Huong V Nguyen,* Katherine B Ingram, Jonathan Beilin


  • 1 Royal Perth Hospital, Box X2213 GPO, Perth, WA 6847
  • 2 Swan District Hospital, Middle Swan, WA



  • 1. Major P. The use of zoledronic acid, a novel, highly potent bisphosphonate for the treatment of hypercalcaemia of malignancy. Oncologist 2000; 7: 481-491.
  • 2. Peters R, Mishra V, Fraser WD. Severe hypocalcaemia after being given intravenous bisphosphonate. BMJ 2004; 328: 335-336.
  • 3. Nowson CA, Margerison C. Vitamin D intake and vitamin D status of Australians. Med J Aust 2002; 177: 149-152. <MJA full text>

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.